Skip to main content

Table 1 Comparison of the baseline clinical characteristics among patients

From: A sex-stratified long-term clinical outcome analysis in coronary chronic total occlusion patients

  Total (n = 563) Men (n = 456) Women (n = 107) p
Age (mean ± SD), years 64.7 ± 10.5 63.6 ± 10.6 69.5 ± 8.7 < 0.001
Hospitalization days 7 (5, 9) 7 (5, 8) 7 (5, 9) 0.425
BMI (mean ± SD), kg/m2 26.03 ± 3.42 26.19 ± 3.42 25.35 ± 3.35 0.022
AC (mean ± SD), cm 93.51 ± 9.86 94.3 ± 9.64 90.07 ± 10.11 < 0.001
Smoke 371 (65.9) 349 (76.5) 22 (20.6) < 0.001
Drink 113 (20.1) 112 (24.6) 1 (0.9) < 0.001
Hypertension 413 (73.4) 321 (70.4) 92 (86) 0.001
Diabetes mellitus 259 (46) 190 (41.7) 69 (64.5) < 0.001
Hyperlipidemia 319 (56.7) 255 (55.9) 64 (59.8) 0.465
CAD 344 (61.1) 267 (58.6) 77 (72) 0.01
Previous MI 126 (22.4) 98 (21.5) 28 (26.2) 0.296
Heart failure 8 (1.4) 5 (1.1) 3 (2.8) 0.179
Chronic kidney disease 34 (6) 26 (5.7) 8 (7.5) 0.488
Peripheral vascular disease 42 (7.5) 32 (7) 10 (9.3) 0.409
Stroke 121 (21.5) 92 (20.2) 29 (27.1) 0.116
History of PCI 176 (31.3) 141 (30.9) 35 (32.7) 0.719
History of CABG 23 (4.1) 21 (4.6) 2 (1.9) 0.198
CHOL(mmol/L) 4.02 ± 106 3.96 ± 1.04 4.32 ± 1.11 0.002
LDL-C(mmol/L) 2.28 ± 0.75 2.24 ± 0.73 2.42 ± 0.79 0.028
eGFR(ml/min) 83.4 ± 22.11 84.68 ± 21.56 77.95 ± 23.67 0.005
NT-proBNPmax (pg/ml) 370 (106.5, 1337.5) 328 (94.53, 1196.75) 582 (135.5, 2152.5) 0.044
  1. Values are n (%), mean ± SD, or median with interquartile range
  2. AC abdominal circumference, CAD coronary artery disease, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, CHOL cholesterol, LDL-c low-density lipoprotein cholesterol, NT-proBNP N-terminal pro-brain natriuretic peptide, eGFR estimated glomerular filtration rate